Academic performance
AI-powered
Australian
bioweapons
bullying
children
cybersecurity threats
heart health
India
IN-SPACE funding
May 2026
NASA
neuro-ophthalmology
New York
Oculis
ozone
pregnancy complications
qualitative data collection
quiz
research
satellites
Smacking
stigma
TakeMe2Space
transformative power
trust
unexplained phenomenon
week's news
Washington D.C.
UCL
trauma
TEMPO
Summit 2026
star tracker
sharing circles
Researchers
Regulation
Queensland
Privosegtor
Physical punishment
ophthalmology
nitrogen dioxide
new format
navigation
miscarriage
job displacement
indigenous communities
imports
global cooperation
clinical trials
care access
Brisbane Times
biopharmaceutical company
Air Pollution
AI
Articles tagged biopharmaceutical company in Science
Oculis to Present New Neuro-Ophthalmic Drug at Summit 2026
Oculis Holding AG, a global biopharmaceutical company based in Zug, Switzerland, will present its breakthrough neuro-ophthalmology drug Privosegtor during upcoming clinical trials at the Summit 2026. This announcement highlights Oculis' ongoing efforts to address significant unmet medical needs in ophthalmology and neuro-ophthalmology.